We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Generex Biotechnology Corporation, the leader in metabolic diseases drug delivery through the inner lining of the mouth, announced that Cardinal Health will distribute its new Glucose RapidSpray product in the U.S. Glucose RapidSpray is expected to be in stores by October, 2006.
Barr Pharmaceuticals, Inc announced that the United States Court of Appeals for the Second Circuit has denied the plaintiffs' petitions for rehearing and rehearing en banc in the Tamoxifen Citrate antitrust lawsuits.
Shares of ImClone Systems Inc. fell over 6 percent on Tuesday after a court invalidated the biotechnology company's ownership of a key cancer drug patent.
Taro Pharmaceutical Industries has filed an abbreviated new drug application (ANDA) for oxcarbazepine tablets, the company announced Sept. 8. Oxcarbazepine, an antiepileptic medication for treating seizures, is currently sold by Novartis as Trileptal.
Patients who take low-dose aspirin to help prevent heart attacks may interfere with that protection if they also take the painkiller ibuprofen, according to an FDA announcement.
The pharmaceutical industry is likely to move past any concerns it has with new user fees if they will help speed the FDA's reviews of DTC advertising, several sources say.
Schering AG, Germany and Bausch & Lomb announced that Schering has granted an exclusive worldwide license to Bausch & Lomb to develop and market a selective glucocorticoid receptor agonist (SEGRA) for the non-systemic treatment of eye disorders.